Melanoma and renal cell carcinoma models similarly show increased oxidative stress upon PON2 knockdown, particularly when combined with chemotherapeutics such as CDDP and 5-FU (Campagna et al. 2020; Schiavoni et al. 2024). This evidence concerns the gene PON2 and melanoma.